The US regulator has cleared Eohilia (formerly TAK-721), an oral suspension formulation of the well-established steroid drug budesonide, for people 11 years and older with EoE after turning down ...

about 75%), oral steroid use, and healthcare utilization. However, during the 14 days after initiation of the study drug, children who received inhaled budesonide or montelukast had significant ...

Prednisone can cause weight gain because it increases fluid retention and appetite. It can also redistribute fat to areas like your face and midsection, increasing their size. Weight gain is a common ...

A common scenario is the patient with EoE who develops heartburn when on well-established EoE nutritional or steroid treatment. There may be a component of poor esophageal acid clearance secondary ...

1 Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Groupement Hospitalier Pitié–Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody ...